Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease.
about
Diabetic Kidney Disease: Pathophysiology and Therapeutic TargetsThe effect of SGLT2 inhibitors on cardiovascular events and renal function.Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients.Effects of glycaemic management on diabetic kidney disease.
P2860
Sodium-glucose cotransport inhibitors: mechanisms, metabolic effects and implications for the treatment of diabetic patients with chronic kidney disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Sodium-glucose cotransport inh ...... s with chronic kidney disease.
@en
type
label
Sodium-glucose cotransport inh ...... s with chronic kidney disease.
@en
prefLabel
Sodium-glucose cotransport inh ...... s with chronic kidney disease.
@en
P2860
P356
P1476
Sodium-glucose cotransport inh ...... s with chronic kidney disease.
@en
P2093
George Vlotides
Peter R Mertens
P2860
P304
P356
10.1093/NDT/GFU299
P407
P577
2014-09-17T00:00:00Z